You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

  • Authors: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Christianne N. Heck, MD, MMM, FAES; Lawrence J. Hirsch, MD
  • CME / CE Released: 1/28/2022
  • Valid for credit through: 1/28/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    Nurses - 1.00 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for epileptologists, neurologists, neurosurgeons, pediatricians, nurses, physician assistants, and pharmacists.

The goal of this activity is to increase awareness of drug-resistant epilepsy (DRE), the differential impact of uncontrolled seizures across the lifespan of patients, and the role of neuromodulation in reducing seizure burden in patients with DRE.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Factors involved in the identification of patients with DRE who are candidates for neuromodulation 
    • Factors to communicate between providers when patient care transitions from pediatric to adult management 
    • Nonseizure consequences associated with poorly controlled seizures 


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

    Professor and Chief of Pediatric Neurology
    Le Bonheur Chair in Pediatric Neurology
    University of Tennessee Health Sciences Center
    Director, Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute
    Le Bonheur Children's Hospital
    Memphis, Tennessee

    Disclosures

    Disclosure: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES, has the following relevant financial relationships:
    Grants for clinical research from: Aucta; Avexis; Envision; Epiwatch; Marinus; Neurecrine; Neurelis; Neuro Event Labs; NeuroPace; SKL SI; Stoke; UCB, Xenon 
    Advisor or consultant for: BioMarin; Eisai; Marinus; Neurelis; Neuro Event Labs; Supernus
    Speaker or member of speakers bureau for: Aquestive; BioMarin; Eisai; Greenwich; Neurelis; LivaNova; SKL SI; Supernus; UCB; Zogenix

  • Christianne N. Heck, MD, MMM, FAES

    Professor of Clinical Neurology
    Keck School of Medicine of USC
    Los Angeles, California

    Disclosures

    Disclosure: Christianne N. Heck, MD, MMM, FAES, has the following relevant financial relationships:
    Grants for clinical research from: Neuropace

  • Lawrence J. Hirsch, MD

    Professor of Neurology
    Chief, Division of Epilepsy and EEG
    Co-Director, Comprehensive Epilepsy Center
    Yale University
    New Haven, Connecticut

    Disclosures

    Disclosure: Lawrence J. Hirsch, MD, has the following relevant financial relationships:
    Advisor or consultant for: Accure; Aquestive; Ceribell; Eisai; Marinus; Medtronic; Neurelis; Neuropace; UCB
    Speaker or member of speakers bureau for: Neuropace; Natus; UCB

Editors

  • Christina T. Loguidice, BA

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Christina T. Loguidice, BA, has disclosed no relevant financial relationships.

  • Ruwaida Vakil, MSc

    Medical Writer, Medscape, LLC

    Disclosures

    Disclosure: Ruwaida Vakil, MSc, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Clinical Recommendations in Drug-Resistant Epilepsy: Approaches to Neuromodulation Across the Age Spectrum

Authors: James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES; Christianne N. Heck, MD, MMM, FAES; Lawrence J. Hirsch, MDFaculty and Disclosures

CME / CE Released: 1/28/2022

Valid for credit through: 1/28/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Early Intervention in Drug-Resistant Epilepsy in Pediatric Patients

Understand available treatment options, including neuromodulation, for pediatric patients with drug-resistant epilepsy.
James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES

Understanding Neuromodulation in Adult Patients With DRE

Explore the pros and cons of various neuromodulation approaches for adult patients with drug-resistant epilepsy.
Christianne N. Heck, MD, MMM, FAES

Life With DRE: More Than Just Seizure Burden

Understand the consequences of poorly controlled seizures, including impact on body systems beyond the brain.
Lawrence J. Hirsch, MD